Promising Immunotherapies against COVID-19

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has resulted in a global pandemic.
• SARS-CoV-2 infection can lead to uncontrolled inflammation and impaired antiviral responses, worsening disease severity.
• Restoring immune function is crucial for effective COVID-19 treatment.

Purpose of the Study:

• To review current immunotherapies for COVID-19.
• To highlight the potential of interferons, anti-inflammatory treatments, and convalescent plasma.

Main Methods:

• Literature review of studies on COVID-19 immunotherapies.
• Focus on treatments targeting immune responses and inflammation.
• Analysis of therapeutic options including interferons, cytokine inhibitors, and convalescent plasma.

Main Results:

• Early interferon administration may prevent COVID-19 exacerbation and promote recovery.
• Inhibiting inflammation can mitigate cytokine storms and multi-organ damage.
• Convalescent plasma with neutralizing antibodies was an early therapeutic option.

Conclusions:

• Immunotherapies offer promising avenues for COVID-19 treatment.
• Targeting immune dysregulation is key to managing severe COVID-19.
• Further research into these immunotherapeutic strategies is warranted.